HEADER TRANSFERASE 26-FEB-08 3CD8 TITLE X-RAY STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN, C-MET KINASE DOMAIN; COMPND 5 SYNONYM: HGF RECEPTOR, SCATTER FACTOR RECEPTOR, SF RECEPTOR, HGF/SF COMPND 6 RECEPTOR, MET PROTO-ONCOGENE TYROSINE KINASE, C-MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS C-MET, KINASE, TRIAZOLOPYRIDAZINE, ATP-BINDING, GLYCOPROTEIN, KEYWDS 2 MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, PROTO-ONCOGENE, KEYWDS 3 RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR S.F.BELLON,B.K.ALBRECHT,J.-C.HARMANGE,D.BAUER,D.CHOQUETTE,I.DUSSAULT REVDAT 4 30-AUG-23 3CD8 1 REMARK SEQADV REVDAT 3 24-FEB-09 3CD8 1 VERSN REVDAT 2 27-MAY-08 3CD8 1 JRNL REVDAT 1 29-APR-08 3CD8 0 JRNL AUTH B.K.ALBRECHT,J.C.HARMANGE,D.BAUER,L.BERRY,C.BODE,A.A.BOEZIO, JRNL AUTH 2 A.CHEN,D.CHOQUETTE,I.DUSSAULT,C.FRIDRICH,S.HIRAI,D.HOFFMAN, JRNL AUTH 3 J.F.LARROW,P.KAPLAN-LEFKO,J.LIN,J.LOHMAN,A.M.LONG, JRNL AUTH 4 J.MORIGUCHI,A.O'CONNOR,M.H.POTASHMAN,M.REESE,K.REX, JRNL AUTH 5 A.SIEGMUND,K.SHAH,R.SHIMANOVICH,S.K.SPRINGER,Y.TEFFERA, JRNL AUTH 6 Y.YANG,Y.ZHANG,S.F.BELLON JRNL TITL DISCOVERY AND OPTIMIZATION OF TRIAZOLOPYRIDAZINES AS POTENT JRNL TITL 2 AND SELECTIVE INHIBITORS OF THE C-MET KINASE. JRNL REF J.MED.CHEM. V. 51 2879 2008 JRNL REFN ISSN 0022-2623 JRNL PMID 18426196 JRNL DOI 10.1021/JM800043G REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 18215 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.236 REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 973 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1089 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.35 REMARK 3 BIN R VALUE (WORKING SET) : 0.2830 REMARK 3 BIN FREE R VALUE SET COUNT : 72 REMARK 3 BIN FREE R VALUE : 0.3090 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2185 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 140 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.19 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.74000 REMARK 3 B22 (A**2) : 2.99000 REMARK 3 B33 (A**2) : -2.25000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.251 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.214 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.142 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.938 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.927 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.893 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2279 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3092 ; 1.105 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 275 ; 5.189 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 93 ;33.953 ;23.333 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 375 ;13.747 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 11 ;14.852 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 344 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1704 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1023 ; 0.176 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1538 ; 0.301 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 134 ; 0.126 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 41 ; 0.105 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.109 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1433 ; 0.554 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2236 ; 0.907 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1000 ; 0.994 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 855 ; 1.444 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3CD8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-FEB-08. REMARK 100 THE DEPOSITION ID IS D_1000046632. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 130 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NONE REMARK 200 OPTICS : VARIMAX OPTICS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19263 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 29.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.19300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 2RFN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES PH 7.8, 15% PEG 4K, 6% 2 REMARK 280 -PROPANOL, 40MM BME, AND 3% ETHANOL, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.00400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.10950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 21.60400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.10950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.00400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 21.60400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1047 REMARK 465 GLN A 1048 REMARK 465 ASN A 1049 REMARK 465 THR A 1050 REMARK 465 VAL A 1051 REMARK 465 HIS A 1052 REMARK 465 ILE A 1053 REMARK 465 LEU A 1098 REMARK 465 ASP A 1099 REMARK 465 ASN A 1100 REMARK 465 ASP A 1101 REMARK 465 GLY A 1102 REMARK 465 LYS A 1103 REMARK 465 THR A 1116 REMARK 465 ASP A 1117 REMARK 465 ILE A 1118 REMARK 465 LEU A 1147 REMARK 465 ARG A 1148 REMARK 465 SER A 1149 REMARK 465 GLU A 1150 REMARK 465 GLY A 1151 REMARK 465 ASN A 1239 REMARK 465 GLU A 1347 REMARK 465 HIS A 1348 REMARK 465 TYR A 1349 REMARK 465 VAL A 1350 REMARK 465 HIS A 1351 REMARK 465 HIS A 1352 REMARK 465 HIS A 1353 REMARK 465 HIS A 1354 REMARK 465 HIS A 1355 REMARK 465 HIS A 1356 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A1064 CG CD OE1 NE2 REMARK 470 LYS A1104 CG CD CE NZ REMARK 470 ILE A1115 CG1 CG2 CD1 REMARK 470 ARG A1227 CG CD NE CZ NH1 NH2 REMARK 470 LYS A1232 CG CD CE NZ REMARK 470 LYS A1240 CG CD CE NZ REMARK 470 THR A1241 OG1 CG2 REMARK 470 LYS A1259 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A1174 132.63 71.72 REMARK 500 ARG A1203 -21.55 78.10 REMARK 500 ASP A1204 43.57 -141.92 REMARK 500 ALA A1221 -155.49 -125.89 REMARK 500 THR A1289 -114.89 41.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L5G A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3CCN RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH TRIAZOLOPYRIDAZINE INHIBITOR. DBREF 3CD8 A 1048 1350 UNP P08581 MET_HUMAN 1048 1350 SEQADV 3CD8 MET A 1047 UNP P08581 INITIATING METHIONINE SEQADV 3CD8 LEU A 1272 UNP P08581 VAL 1272 VARIANT SEQADV 3CD8 HIS A 1351 UNP P08581 EXPRESSION TAG SEQADV 3CD8 HIS A 1352 UNP P08581 EXPRESSION TAG SEQADV 3CD8 HIS A 1353 UNP P08581 EXPRESSION TAG SEQADV 3CD8 HIS A 1354 UNP P08581 EXPRESSION TAG SEQADV 3CD8 HIS A 1355 UNP P08581 EXPRESSION TAG SEQADV 3CD8 HIS A 1356 UNP P08581 EXPRESSION TAG SEQRES 1 A 310 MET GLN ASN THR VAL HIS ILE ASP LEU SER ALA LEU ASN SEQRES 2 A 310 PRO GLU LEU VAL GLN ALA VAL GLN HIS VAL VAL ILE GLY SEQRES 3 A 310 PRO SER SER LEU ILE VAL HIS PHE ASN GLU VAL ILE GLY SEQRES 4 A 310 ARG GLY HIS PHE GLY CYS VAL TYR HIS GLY THR LEU LEU SEQRES 5 A 310 ASP ASN ASP GLY LYS LYS ILE HIS CYS ALA VAL LYS SER SEQRES 6 A 310 LEU ASN ARG ILE THR ASP ILE GLY GLU VAL SER GLN PHE SEQRES 7 A 310 LEU THR GLU GLY ILE ILE MET LYS ASP PHE SER HIS PRO SEQRES 8 A 310 ASN VAL LEU SER LEU LEU GLY ILE CYS LEU ARG SER GLU SEQRES 9 A 310 GLY SER PRO LEU VAL VAL LEU PRO TYR MET LYS HIS GLY SEQRES 10 A 310 ASP LEU ARG ASN PHE ILE ARG ASN GLU THR HIS ASN PRO SEQRES 11 A 310 THR VAL LYS ASP LEU ILE GLY PHE GLY LEU GLN VAL ALA SEQRES 12 A 310 LYS GLY MET LYS TYR LEU ALA SER LYS LYS PHE VAL HIS SEQRES 13 A 310 ARG ASP LEU ALA ALA ARG ASN CYS MET LEU ASP GLU LYS SEQRES 14 A 310 PHE THR VAL LYS VAL ALA ASP PHE GLY LEU ALA ARG ASP SEQRES 15 A 310 MET TYR ASP LYS GLU TYR TYR SER VAL HIS ASN LYS THR SEQRES 16 A 310 GLY ALA LYS LEU PRO VAL LYS TRP MET ALA LEU GLU SER SEQRES 17 A 310 LEU GLN THR GLN LYS PHE THR THR LYS SER ASP VAL TRP SEQRES 18 A 310 SER PHE GLY VAL LEU LEU TRP GLU LEU MET THR ARG GLY SEQRES 19 A 310 ALA PRO PRO TYR PRO ASP VAL ASN THR PHE ASP ILE THR SEQRES 20 A 310 VAL TYR LEU LEU GLN GLY ARG ARG LEU LEU GLN PRO GLU SEQRES 21 A 310 TYR CYS PRO ASP PRO LEU TYR GLU VAL MET LEU LYS CYS SEQRES 22 A 310 TRP HIS PRO LYS ALA GLU MET ARG PRO SER PHE SER GLU SEQRES 23 A 310 LEU VAL SER ARG ILE SER ALA ILE PHE SER THR PHE ILE SEQRES 24 A 310 GLY GLU HIS TYR VAL HIS HIS HIS HIS HIS HIS HET L5G A 1 29 HETNAM L5G 7-METHOXY-4-[(6-PHENYL[1,2,4]TRIAZOLO[4,3-B]PYRIDAZIN- HETNAM 2 L5G 3-YL)METHOXY]QUINOLINE FORMUL 2 L5G C22 H17 N5 O2 FORMUL 3 HOH *140(H2 O) HELIX 1 1 ASP A 1054 LEU A 1058 5 5 HELIX 2 2 LEU A 1062 GLN A 1064 5 3 HELIX 3 3 ALA A 1065 VAL A 1070 1 6 HELIX 4 4 GLU A 1120 PHE A 1134 1 15 HELIX 5 5 ASP A 1164 ASN A 1171 1 8 HELIX 6 6 THR A 1177 LYS A 1198 1 22 HELIX 7 7 ALA A 1206 ARG A 1208 5 3 HELIX 8 8 PHE A 1223 ARG A 1227 5 5 HELIX 9 9 ASP A 1231 TYR A 1235 5 5 HELIX 10 10 PRO A 1246 MET A 1250 5 5 HELIX 11 11 ALA A 1251 GLN A 1258 1 8 HELIX 12 12 THR A 1261 THR A 1278 1 18 HELIX 13 13 ASN A 1288 PHE A 1290 5 3 HELIX 14 14 ASP A 1291 GLN A 1298 1 8 HELIX 15 15 PRO A 1309 TRP A 1320 1 12 HELIX 16 16 LYS A 1323 ARG A 1327 5 5 HELIX 17 17 SER A 1329 THR A 1343 1 15 SHEET 1 A 5 ILE A1077 ARG A1086 0 SHEET 2 A 5 CYS A1091 THR A1096 -1 O HIS A1094 N HIS A1079 SHEET 3 A 5 HIS A1106 LYS A1110 -1 O CYS A1107 N GLY A1095 SHEET 4 A 5 LEU A1154 PRO A1158 -1 O LEU A1157 N ALA A1108 SHEET 5 A 5 GLY A1144 CYS A1146 -1 N CYS A1146 O LEU A1154 SHEET 1 B 2 CYS A1210 LEU A1212 0 SHEET 2 B 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 C 2 SER A1236 VAL A1237 0 SHEET 2 C 2 LYS A1244 LEU A1245 -1 O LEU A1245 N SER A1236 SITE 1 AC1 11 ILE A1084 ALA A1108 PRO A1158 TYR A1159 SITE 2 AC1 11 MET A1160 ASP A1164 ARG A1208 MET A1211 SITE 3 AC1 11 ALA A1221 ASP A1222 TYR A1230 CRYST1 42.008 43.208 158.219 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023805 0.000000 0.000000 0.00000 SCALE2 0.000000 0.023144 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006320 0.00000